SARCULATOR im Vergleich zu ASCO Guidelines Nutzung und Statistiken

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

SARCULATORvs. ASCO Guidelines Ranking-Vergleich

Vergleichen Sie SARCULATOR den Ranking-Trend der letzten 28 Tage mit ASCO Guidelines

Rang

Keine Daten verfügbar

SARCULATOR im Vergleich zu ASCO Guidelines Ranking im Ländervergleich

Vergleichen Sie SARCULATOR den Ranking-Trend der letzten 28 Tage mit ASCO Guidelines

Alle Kategorien

Keine Daten verfügbar

Medizin

App
Top-Land
Rang
- -
- -
#174

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
SARCULATOR VS.
ASCO Guidelines

Januar 8, 2025